Welcome : Guest

Ion Beam Applications S.A. (Belgium) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Ion Beam Applications S.A., which is principally involved in providing Advanced Cancer Radiation Therapy Technologies. Illustrated with 35 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-08127
Price: $1750
Company Type: Public
Pages: 37
Date: November 2016
Market Data Tables: 35

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Ion Beam Applications S.A.'s Sales by Business Segment Worldwide (2014-2015) in Percentage for Proton Therapy and Other Accelerators, and Dosimetry......3
Table 2: Ion Beam Applications S.A.'s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Belgium, USA, and Rest of the World......4
Radiotherapy......5
Table 3: Radiotherapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Americas, Asia-Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Japan......5
Molecular Monitoring Oncology......6
Table 4: Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......6
Breast Cancer Diagnoses......7
Table 5: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......7
Diagnostic Imaging Devices......8
Table 6: Diagnostic Imaging Devices Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Electrodiagnostic Equipment, Imaging Equipment and Accessories, and Radiation Equipment......8
Clinical Oncology......9
Table 7: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......9
Diagnostic Test......10
Table 8: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......10
Table 9: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......11
Molecular Diagnostics and Genetic Testing......12
Table 10: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Others......12
Hematological Cancer......13
Table 11: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin's Lymphoma (NHL)......13
Cancer Care......14
Table 12: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......14
Table 13: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......15
Table 14: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......16
Cancer-Associated Mucositis......17
Table 15: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......17
Hereditary Oncology......18
Table 16: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......18
New Patients with Cancer......19
Table 17: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......19
Table 18: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......20
No. of Primary Liver Cancer......21
Table 19: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......21
No. of Solid Cancer Tumor Patients......22
Table 20: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......22
Number of Cancer Patients......23
Table 21: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......23
Table 22: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......24
Oncology......25
Table 23: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......25
Table 24: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......26
Table 25: Oncology Market by Product Segment Worldwide (2015) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......27
Table 26: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......28
Oncology......29
Table 27: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......29
Radiation Oncology Equipment......30
Table 28: Market Shares of Leading Radiation Oncology Equipment Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Elekta, Siemens AG, Varian Medical Systems and Others......30
Radiotherapy Equipment (High-End)......31
Table 29: Market Shares of Leading Radiotherapy Equipment Providers in China (2015) - Percentage Breakdown by Value for Elekta, Neusoft Corporation, Shinva Medical Instrument Co., Ltd., Siemens AG, and Varian, Inc.......31
Table 30: Market Shares of Leading Radiotherapy Treatment Companies Worldwide (2015) - Percentage Share Breakdown by Volume for Accuray Incorporated, Elekta, Siemens Healthcare, and Varian Medical Systems......32
Table 31: Market Shares of Leading High-End Radiotherapy Equipment Manufacturers in China (2015) - Percentage Share Breakdown by Value for Elekta, SHINVA Medical Instrument Co., Ltd., Varian Medical Systems and Others......33
Table 32: Market Shares of Leading High-End Radiotherapy Equipment Manufacturers in China (2015) - Percentage Share Breakdown by Value for Elekta AB, SHINVA Medical Instrument Co., Ltd., Siemens Healthcare Global, Varian Medical Systems, and Others......34
Cancer Genetic Diagnostics......35
Table 33: Market Shares of Leading Cancer Genetic Diagnostics Reference Laboratory Services in the US (2015) - Percentage Breakdown by Value Sales for ARUP Laboratories, Clarient Diagnostic Services, Inc., Laboratory Corporation of America Holdings, Mayo Medical Laboratories, NeoGenomics, Inc., Quest Diagnostics Incorporated and AmeriPath, Inc., and Others......35
Table 34: Ion Beam Applications S.A.'s Sales by Geographic Region Worldwide (2014) in Percentage for Belgium, USA and Rest of the World......36
Table 35: Ion Beam Applications S.A.'s Sales by Business Segment Worldwide (2014-2013) in Percentage for Proton Therapy and Other Accelerators and Dosimetry......37